FYN: S-{(9R,13S,15R)-17-[(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]-9,13,15-TRIHYDROXY-10,10-DIMETHYL-13,15-DIOXIDO-4,8-DIOXO-12,14,16-TRIOXA-3,7-DIAZA-13,15-DIPHOSPHAHEPTADEC-1-YL} THIOFORMATE
FYN is a Ligand Of Interest in 8VZF designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
8VZF_FYN_C_601 | 88% | 53% | 0.077 | 0.953 | 0.8 | 1.03 | 1 | 2 | 7 | 0 | 100% | 0.9782 |
8VZF_FYN_D_601 | 86% | 51% | 0.078 | 0.945 | 0.83 | 1.07 | 3 | 1 | 7 | 0 | 100% | 0.9854 |
8VZF_FYN_B_601 | 85% | 48% | 0.08 | 0.944 | 0.81 | 1.19 | 3 | 3 | 5 | 0 | 100% | 0.9849 |
8VZF_FYN_A_601 | 84% | 52% | 0.083 | 0.946 | 0.8 | 1.06 | 1 | 2 | 4 | 0 | 100% | 0.9825 |
8VZC_FYN_A_602 | 94% | 41% | 0.069 | 0.966 | 0.81 | 1.48 | 1 | 6 | 2 | 0 | 100% | 0.988 |
8VZD_FYN_A_602 | 70% | 53% | 0.096 | 0.915 | 0.79 | 1.03 | 3 | 2 | 2 | 0 | 98% | 0.9697 |
7PT4_FYN_A_715 | 25% | 55% | 0.173 | 0.806 | 0.69 | 1.03 | 1 | 2 | 3 | 0 | 100% | 1 |